Efficacy and safety of a TIA/stroke electronic support tool (FASTEST) trial: Study protocol

Implementation Science

Dea O’Dea¹  Mark Weatherall¹  Susan Dovey²  Annemarei Ranta¹ 

[1] University of Otago-Wellington, Wellington, New Zealand;Dunedin School of Medicine, University of Otago, Dunedin, New Zealand

关键词: Integrated;    Delivery of Healthcare;    Computer-Assisted;    Decision Making;    Decision Support Techniques;    Electronic Decision Support (EDS);    Transient (TIA);    Ischaemic Attack;    Stroke;   

Others  :  813877
DOI  :  10.1186/1748-5908-7-107

 received in 2012-07-23, accepted in 2012-09-25,  发布年份 2012

【 摘 要 】

Background

Strokes are a common cause of adult disability and mortality worldwide. Transient ischaemic attacks (TIA) are associated with a high risk of subsequent stroke, and rapid intervention has the potential to reduce stroke burden. This study will assess a novel electronic decision support (EDS) tool to allow general practitioners (GPs) to implement evidence-based care rapidly without full reliance on specialists.

Methods/design

This is a cluster randomized controlled trial comparing TIA/stroke management of GPs with access to the EDS tool versus usual care. The intervention period is 12 months with a 3-month follow-up period for individual patients. Primary outcomes consist of stroke within 90 days of presenting event and adherence to the New Zealand national TIA guideline.

Discussion

A positive study will provide strong evidence for widespread implementation of this tool in practice and has the potential to improve key outcomes for patients and reduce the burden of stroke.

Trial registration

Australia New Zealand Clinical Trials Registry ACTRN12611000792921

【 授权许可】

   
2012 Ranta et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 4 .

Figure 3.

【 参考文献 】

• [1]Johnston SC, Mendis S, Mathers CD: Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009, 8:345-354.
• [2]Rothwell PM: The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet 2001, 357:1612-1616.
• [3]Brown P: Economic burden of stroke in New Zealand. Three decades of Auckland regional Community Stroke (ARCOS) studies: What have we learned and what is next for stroke care and stroke research?. 16th edition. Auckland, New Zealand: AUT University; 2009.
• [4]Anderson CS, Carter KN, Hackett ML, et al.: Trends in stroke incidence in Auckland, New Zealand, during 1981 to 2003. Stroke 2005, 36:2087-2093.
• [5]Carter KN, Anderson CS, Hackett ML, et al.: Improved survival after stroke: is admission to hospital the major explanation? Trend analyses of the Auckland Regional Community Stroke Studies. Cerebrovasc Dis 2007, 23:162-168.
• [6]Tobias M, Cheung J, Carter K, et al.: Stroke surveillance: population-based estimates and projections for New Zealand. Aust N Z J Public Health 2007, 31:520-525.
• [7]Feigin V: Trends in stroke incidence in Auckland, New Zealand (1981–2003). Three decades of Aucklandregional Community Stroke (ARCOS)studies: what have welearned and what isnext for stroke careand stroke research?. Auckland, New Zealand: AUT University; 2009:8-9.
• [8]Feigin VL, Howard G: The importance of epidemiological studies should not be downplayed. Stroke 2008, 39:1-2.
• [9]Giles MF, Rothwell PM: Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007, 6:1063-1072.
• [10]Lavallee PC, Meseguer E, Abboud H, et al.: A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007, 6:953-960.
• [11]Rothwell PM, Giles MF, Chandratheva A, et al.: Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007, 370:1432-1442.
• [12]Lasserson DS, Chandratheva A, Giles MF, Mant D, Rothwell PM: Influence of general practice opening hours on delay in seeking medical attention after transient ischaemic attack (TIA) and minor stroke: Prospective population based study. BMJ 2008, 337:795-798.
• [13]New Zealand Guideline for the Assessment and Management of People with Recent Transient Ischaemic Attack. Wellington: Stroke Foundation of New Zealand; 2008.
• [14]Chaudhry B, Wang J, Wu S, et al.: Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 2006, 144(10):742-752.
• [15]O'Connor PJ, Sperl-Hillen JM, Rush WA, et al.: Impact of electronic health record clinical decision support on diabetes care: a randomized trial. Ann Fam Med 2011, 9(1):12.
• [16]Main C, Moxham T, Wyatt JC, Kay J, Anderson R, Stein K: Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems. Health Technol Assessment 2010, 14(48):1.
• [17]Pearson S-A, Moxey A, Robertson J, Hains I, Williamson M, Reeve J, Newby D: Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990–2007). BMC Heal Serv Res 2009, 9:154. BioMed Central Full Text
• [18]Mollon B, Chong JJR, Holbrook AM, Sung M, Thabane L, Foster G: Features predicting the success of computerized decision support for prescribing: a systematic review of randomized controlled trials. BMC Med Inform Decis Mak 2009, 9:11. BioMed Central Full Text
• [19]Sintchenko V, Magrabi F, Tipper S: Are we measuring the right end-points? Variables that affect the impact of computerised decision support on patient outcomes: A systematic review. Med Informat & The Internet in Med 2007, 32(3):225-240.
• [20]Kawamoto K, Houlihan CA, Balas EA, Lobach DF: Clinical Practice Improvement and Redesign: How Change in Workflow Can Be Supported by Clinical Decision Support. BMJ 2005, 30(7494):765-8E.
• [21]Garg AX, Adhikari NKJ, McDonald , Rosas-Arellano MP, Devereaux PJ, Bevene J, Sam J, Haynes RB: Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. JAMA 2005, 293(10):1223-1228.
• [22]Ranta A: TIA/Stroke EElectronic Decision Support: An 8-week pilot. Journal of Primary Health Care 2012.
• [23]Ranta A: Is there a place for electronic decision support in transient ischaemic attack and stroke management? Int J Stroke 2010, 5(s1):13.
• [24]Ranta A, Yang CF, Cogger N: TIA/Stroke Electronic Decision Support: A before and after study. In Proceedings for Sroke Society of Australia Annual Meeting. Sydney: Int J Stroke; 2012.
• [25]Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al.: Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007, 369:283-292.
• [26]Friedman LM, Furburg CD, De Mets D: Fundamentals of Clinical Trials. 121st edition. New York: Springer Verlag; 1999.
• [27]Adams G, et al.: Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol 2004, 57:785-794.
• [28]Donner A, Klar N: Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. Am J Epidemiol 1994, 140:279-289.
• [29]Little RC, et al.: SAS for Mixed Models. 2nd edition. Cary, NC: SAS Institute Inc; 2006.
• [30]Brown H, Prescott R: Applied Mixed Models in Medicine. 2nd edition. Chichester: John Wiley & Sons; 2006.
• [31]Drummond MF, Schulpher MJ, Torrance GW, et al.: Methods for the economicevaluation of health careprogrammes. Chapter 8. 3rd edition. Oxford University; 2005.
• [32]Pharmac: Prescription for Pharmacoeconomic Analysis. Methods for cost-utility analysis. Version 2.1. 2012. http://www.pharmac.govt.nz/EconomicAnalysis/pharmacoeconomics webcite
• [33]Pharmac: Cost Resource Manual forPFPA. Version 2.11. 2012. http://www.pharmac.govt.nz/EconomicAnalysis/pharmacoeconomics webcite